Genenta Science S.p.A GNTA
NASDAQ GNTA
$0.66 +0.03 (+4.76%)
At close: Nov 9, 2026 · 4:00 PM EST

Genenta Science S.p.A (GNTA) Receivables (2024)

Updated

Genenta Science S.p.A (GNTA) recorded Receivables of $115,408 in the quarter ended Dec 31, 2024.

Analysis

Genenta Science S.p.A (GNTA) Receivables (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 25.23 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 18.99 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 13.51 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 12.74 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 16.16 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.35 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 5.01 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.19 Bn
10 Genenta Science S.p.A 15.47 Mn -69.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 112,386.44
Jun 30, 2024 115,651.51
API Access

Genenta Science S.p.A Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=GNTA&period=max&api_key=YOUR_API_KEY